Trial Profile
Clinical Trials Insight: 700014389
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jul 2019
Price :
$35
*
At a glance
- Drugs Peptide YY 3-36 (Primary) ; Peptide YY 3-36 (Primary)
- Indications Obesity
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Adhera Therapeutics
- 22 Dec 2006 Status changed from in progress to completed
- 17 Aug 2006 The expected completion date for this trial is now 1 Sep 2006.
- 17 Aug 2006 New trial record.